Evidence map›Paper›PMID 26936845›Full record

ArticleEndocrine pathology2016

The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.

Sule Ozturk Sari, Orhun Cig Taskin, Gokcen Gundogdu, Gulcin Yegen, Semen Onder, Metin Keskin, Sezer Saglam, Yasemin Ozluk, Mine Gulluoglu, Ozgur Mete

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Endocrine pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Quantitative Assessment of Epithelial Proliferation in Rat Mammary Gland Using Artificial Intelligence Independent of Choice of Proliferation Marker.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Sule Ozturk SariDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. suleozturksari@gmail.com.
Orhun Cig TaskinDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Gokcen GundogduDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Gulcin YegenDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Semen OnderDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Metin KeskinDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Sezer SaglamDepartment of Medical Oncology, University of Bilim, Istanbul, Turkey.
Yasemin OzlukDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Mine GulluogluDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Ozgur MeteDepartment of Pathology, University Health Network, Toronto, ON, Canada.
Istanbul University · TRIstanbul Bilim University · TRUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the impact of phosphohistone-H3 (PHH3)-assisted mitotic count by comparing its performance with conventional mitotic count and Ki67 score as well as the status of distant metastasis. A total of 43 surgically resected pancreatic neuroendocrine tumors (panNET) with complete follow-up information has been subjected to a standardized assessment with respect to mitotic count (both conventional and PHH3-assisted) and Ki67 score. Five participants assessed mitotic count and the time spent was recorded in both methods. All tumors were assigned to a G1 category of mitotic rate on conventional mitotic count that failed to identify three tumors with a G2 category of mitotic rate on PHH3. Near-perfect and fair agreements were achieved among observers when using PHH3 and conventional method, respectively. The mean time spent to determine mitotic count on PHH3-stained slides was significantly shorter (p < 0.001). The performance of PHH3-assisted mitotic grade category was significant as the three cases with a G2 mitotic category were associated with distant metastasis (p = 0.01). Despite its performance, the PHH3-assisted mitotic count downgraded 17 cases that were classified as G2 based on Ki67 scores in this series. The Ki67 grade category was either the same or higher than the mitotic grade category. Ten patients developed distant metastasis. Eleven tumors exhibited vascular invasion characterized by intravascular tumor cells admixed with thrombus. Our results indicate that PHH3-assisted mitotic count facilitates an accurate mitotic count with a perfect agreement among observers. The small size of this cohort is an important limitation of the current study, a G2 mitotic grade category based on PHH3 immunohistochemistry was one of the correlates of panNETs with distant metastasis. While the prognostic impact of PHH3-assisted mitotic count needs to be clarified in larger cohorts, Ki67 scores designated higher grade category in all cases; thus, it was the best determinant of the tumor grade. More importantly, the presence of vascular invasion along with the Ki67 grade category was found to be independent predictors of distant metastasis.

Indexed as

AdultAgedDisease-Free SurvivalFemaleHistonesHumansImmunohistochemistryKaplan-Meier EstimateKi-67 AntigenMaleMiddle AgedMitotic IndexNeoplasm GradingNeoplasm MetastasisNeuroendocrine TumorsObserver VariationHistonesKi-67 AntigenGradeKi67Mitotic countPancreatic neuroendocrine tumorPhosphohistone-H3Vascular invasion

Identifiers

PMID26936845
OpenAlexW2293514492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.